Faculty, Staff and Student Publications
Publication Date
3-1-2024
Journal
Autophagy
DOI
10.1080/15548627.2023.2299516
PMID
38169324
PMCID
PMC10936598
PubMedCentral® Posted Date
1-3-2024
PubMedCentral® Full Text Version
Post-print
Abstract
Pancreatic ductal adenocarcinoma (PDAC) and low-grade ovarian cancer (LGSOC) are characterized by the prevalence of KRAS oncogene mutations. DIRAS3 is the first endogenous non-RAS protein that heterodimerizes with RAS, disrupts RAS clustering, blocks RAS signaling, and inhibits cancer cell growth. Here, we found that DIRAS3-mediated KRAS inhibition induces ROS-mediated apoptosis in PDAC and LGSOC cells with KRAS mutations, but not in cells with wild-type KRAS, by downregulating NFE2L2/Nrf2 transcription, reducing antioxidants, and inducing oxidative stress. DIRAS3 also induces cytoprotective macroautophagy/autophagy that may protect mutant KRAS cancer cells from oxidative stress, by inhibiting mutant KRAS, activating the STK11/LKB1-PRKAA/AMPK pathway, increasing lysosomal CDKN1B/p27 localization, and inducing autophagic gene expression. Treatment with chloroquine or the novel dimeric chloroquine analog DC661 significantly enhances DIRAS3-mediated inhibition of mutant KRAS tumor cell growth in vitro and in vivo. Taken together, our study demonstrates that DIRAS3 plays a critical role in regulating mutant KRAS-driven oncogenesis in PDAC and LGSOC.
Keywords
Female, Humans, Proto-Oncogene Proteins p21(ras), Reactive Oxygen Species, Cell Line, Tumor, Autophagy, Ovarian Neoplasms, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Chloroquine
Published Open-Access
yes
Recommended Citation
Bildik, Gamze; Gray, Joshua P; Mao, Weiqun; et al., "DIRAS3 Induces Autophagy and Enhances Sensitivity to Anti-Autophagic Therapy in KRAS-Driven Pancreatic and Ovarian Carcinomas" (2024). Faculty, Staff and Student Publications. 2568.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/2568
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Medical Sciences Commons, Obstetrics and Gynecology Commons, Oncology Commons, Women's Health Commons